Overview

Prevention Of Recurrence Of Atrial Fibrillation

Status:
Completed

Trial end date:
2003-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the study drug is effective in preventing the recurrence of atrial fibrillation (an abnormal heart rhythm).

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline